ALIVE Israel Healthtech Fund

ALIVE Israel HealthTech Fund is a venture capital investment firm established in 2020 and located in Tel Aviv, Israel. The fund specializes in investing in mid-to-late stage companies within the health-tech sector, leveraging a unique ecosystem to identify and support innovative health technologies. By focusing on this dynamic field, ALIVE aims to foster the growth of promising health-tech ventures that can significantly impact the healthcare landscape.

Rafael Beyar

Co-Founder, Managing General Partner

Michel Habib

Co-Founder, Managing General Partner

Dudi Klein

Co-Founder, Managing Partner

Ari Shamiss

Co-Founder and Managing General Partner

Ari Shamiss

Co-Founder, Managing General Partner

6 past transactions

Magenta Medical

Venture Round in 2023
Magenta Medical Ltd., founded in 2012 and based in Kadima, Israel, specializes in developing innovative device solutions for the treatment of acute and chronic heart failure. The company's primary focus is on a temporary venous catheter-based therapy designed specifically for patients experiencing acute decompensated heart failure. By addressing critical needs within this medical field, Magenta Medical aims to improve patient outcomes through its advanced therapeutic technologies.

Thesis

Series A in 2023
Provider of supplements intended to make the brain more effective. The company's supplements are personalized according to the user's needs and provide on-demand focus, energy and productivity, enabling consumers who struggle with brain fog and burnout to get access to a tailored product for their unique biology and daily activities.

OncoHost

Series C in 2022
OncoHost is a clinical-stage biotechnology company focused on enhancing cancer therapy outcomes through personalized strategies. Founded in 2017 and headquartered in Binyamina, Israel, the company employs proprietary proteomic analysis to evaluate individual patient responses to treatments, addressing the critical challenge of therapy resistance in oncology. By analyzing proteomic changes in blood samples, OncoHost’s platform facilitates the early identification of non-responsiveness to cancer therapies and aids in discovering new drug targets. The integration of bioinformatics, systems biology, and machine learning allows OncoHost to predict clinical benefits from specific therapies, which can guide healthcare providers in tailoring treatment plans. Collaborating with leading academic and clinical partners, OncoHost is advancing its clinical programs to improve patient outcomes through personalized diagnostics and therapeutic strategies.

Beyeonics

Venture Round in 2021
Beyeonics Surgical Technologies, founded in 2012 and based in Haifa, Israel, specializes in innovative visualization technologies aimed at enhancing surgical procedures. The company develops augmented and virtual reality systems that improve surgeon efficiency and patient safety while delivering superior surgical outcomes. Beyeonics offers solutions for various applications, including spine surgery, minimally invasive procedures, robotic surgery, and cardiovascular catheterization labs. The technology replaces traditional surgical microscopes, allowing for the real-time integration of extensive data during operations. Collaborations with medical professionals, such as those from the Tel Aviv Sourasky Medical Center and Retinal Consultants of Arizona, further support the company's mission to revolutionize surgical visualization. Beyeonics operates as a subsidiary of Elbit Systems Ltd.

Cynerio

Series B in 2021
Cynerio Israel Ltd is a cybersecurity company that focuses on protecting healthcare providers from cyber threats targeting patient data and connected medical devices. Founded in 2017 and headquartered in Tel Aviv, Israel, Cynerio offers a platform that utilizes device behavior learning and medical workflow analysis to ensure comprehensive visibility into device activities on the network. This capability allows for the detection of anomalous behavior and the mitigation of associated risks, thereby enhancing the security of sensitive healthcare information and equipment.

Innovalve

Venture Round in 2020
Innovalve is an early-stage medical device company that develops catheter-based heart valve therapies. The company was founded in 2017 and is based in Israel.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.